Let Your Rabid Leftist Friends And Family Go
Outgoing Biden Admin Exposed for Special Interest Corruption
A Quick Bible Study Vol. 243: What the New Testament Says About Fearing...
The Forever-Tarnished Legacy of Barack Obama
Avoiding Self-Inflicted Trade and Economic Wounds
Giving Thanks Is Good For You
The Hidden Pro-Life Message You Missed at Miss Universe
The Border's Broken Vetting System: Why We Can't Wait to Fix It
Can We Take Back the English Language Now?
Trump's Strategy On Iran Could End Middle East Wars
Trump Names His New Agriculture Secretary
Bombshell Report Reveals Disturbing Truths About the Biden-Harris Parole Pipeline
Gen. Milley Makes Stunning Admission About Incoming Trump Administration
ICE Sends Hochul Grim Warning After Arresting Wanted Illegal Immigrant
Sickening: An Illegal Alien Allegedly Raped a 14-Year-Old Girl in Colorado
Tipsheet

The CDC Director Just Gave Us an Updated Vaccine Timeline

AP Photo/Alex Brandon

We've brought you a lot of exciting vaccine news these past few weeks. And there's more of it on Tuesday. Center for Disease Control Director Robert Redfield said Americans should expect a vaccine to be rolled out very, very soon. He predicted the second week of December.

Advertisement

The next question then is, who will be receiving the first doses. He answered that too.

In an interview with Fox News anchor Dana Perino, Redfield shared that the first groups to get the vaccine will probably be "nursing home residents and then some combination of health care providers and individuals at high risk for a poor outcome."

"I do think we'll have about 40 million doses of vaccine before the end of the...year," Redfield continued. "That's enough to vaccinate 20 million people. But then it will continue through January and February and hopefully by March we'll start to see vaccine available for the general public."

Advertisement

Pfizer, who vaccine its been developing with BioNTech has produced a 95 percent efficacy rate, requested an emergency authorization from the FDA. A second vaccine candidate being produced by Moderna isn't too far behind, reporting a 94 percent effectiveness. And then a third, developed by AstraZeneca, is up to 90 percent effective.

The FDA has reportedly scheduled a meeting for Dec. 10 with its Vaccines and Related Biological Products Advisory Committee to discuss Pfizer's request.

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement